Literature DB >> 2328728

Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.

M M Müller-Immerglück1, W Schaffner, P Matthias.   

Abstract

In non-lymphoid cells such as HeLa cells, ectopic expression of the lymphocyte-specific transcription factor Oct-2A can activate reporter genes whose promoters consist of a single octamer sequence (ATTTGCAT) upstream of a TATA box. While the factor is strongly active in a promoter position, it tails as an enhancer factor: an enhancer consisting of multiple copies of the octamer sequence placed downstream of the reporter gene is not active in HeLa cells, even at high concentration of Oct-2A. In B lymphoid cells, however, the same enhancer is highly active. This could mean that an additional factor is required for enhancer activation in B cells. Furthermore, we have tested the transcriptional activation potential of Oct-2A with a series of N-terminal and C-terminal deletions. We show that a glutamine-rich domain near the N-terminus is required for full activity. Otherwise, large segments of the N-terminal half or the entire C-terminal region are dispensable in our assay, as long as the deletions do not impinge on the conserved POU domain which is sufficient for DNA binding. While N-terminal and C-terminal regions can functionally compensate for each other, a combined deletion that only retains the POU domain is a strong down mutation. We also find that activity depends on the promoter structure of the reporter gene: the POU domain by itself shows some activity with a promoter where the octamer sequence is located very close to the TATA box, but no activity with another promoter construction where the octamer sequence is located further upstream. The two promoters also respond differently to the deletion of the glutamine-rich stretch important for transcriptional activation. From these experiments we consider it likely that the natural octamer factor variants can selectively activate the different naturally occurring octamer-containing promoters.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328728      PMCID: PMC551858          DOI: 10.1002/j.1460-2075.1990.tb08282.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein.

Authors:  M Bodner; J L Castrillo; L E Theill; T Deerinck; M Ellisman; M Karin
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

2.  A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain.

Authors:  H S Ko; P Fast; W McBride; L M Staudt
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

3.  The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.

Authors:  S Stern; M Tanaka; W Herr
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif.

Authors:  L M Staudt; R G Clerc; H Singh; J H LeBowitz; P A Sharp; D Baltimore
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

6.  No strict alignment is required between a transcriptional activator binding site and the "TATA box" of a yeast gene.

Authors:  D M Ruden; J Ma; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line.

Authors:  D M Zaller; H Yu; L A Eckhardt
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

Authors:  V Kumar; P Chambon
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Constraints on spacing between transcription factor binding sites in a simple adenovirus promoter.

Authors:  L Wu; A Berk
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

10.  A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor.

Authors:  H R Schöler; A K Hatzopoulos; R Balling; N Suzuki; P Gruss
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  62 in total

1.  The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.

Authors:  C P Verrijzer; J A van Oosterhout; P C van der Vliet
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

3.  Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.

Authors:  A Annweiler; M Müller-Immerglück; T Wirth
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  Mapping the transactivation domain of the Oct-6 POU transcription factor.

Authors:  D Meijer; A Graus; G Grosveld
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

5.  Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

Authors:  C M Rudin; U Storb
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

6.  The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core.

Authors:  I M Clauss; M Chu; J L Zhao; L H Glimcher
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

7.  Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.

Authors:  D B Schubart; P Sauter; S Massa; E M Friedl; H Schwarzenbach; P Matthias
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

8.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

9.  Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3.

Authors:  M Imagawa; A Miyamoto; M Shirakawa; H Hamada; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

10.  A novel POU domain protein which binds to the T-cell receptor beta enhancer.

Authors:  H Messier; H Brickner; J Gaikwad; A Fotedar
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.